A FAMILY-BASED APPROACH TO THE TREATMENT OF OBESE TYPE-II DIABETIC-PATIENTS

被引:133
|
作者
WING, RR
MARCUS, MD
EPSTEIN, LH
JAWAD, A
机构
[1] Psychiatry Department, University of Pittsburgh School of Medicine
关键词
D O I
10.1037/0022-006X.59.1.156
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Forty-nine obese diabetic patients with obese spouses (diabetic or nondiabetic) were randomly assigned to an alone or together condition. Patients in the alone group participated by themselves in a 20-week behavioral weight control program; their spouses attended assessment sessions only. Patients in the together group attended the program with their spouses; both were targeted for weight loss and taught social support strategies. Weight losses of patients treated alone and together did not differ significantly at posttreatment (19.9 vs. 19.1 1b) or 1-year follow-up (11.6 vs. 7.0 1b). However, there was a significant interaction of treatment and gender; women did better when treated with their spouses, whereas men did better when treated alone. A "family-based" approach was not effective for these obese Type II diabetic patients as a whole but may be helpful for women.
引用
收藏
页码:156 / 162
页数:7
相关论文
共 50 条
  • [41] A HYPOMETABOLIC EFFECT MAY PREVENT WEIGHT-LOSS IN OBESE MIDDLE-AGE TYPE-II DIABETIC-PATIENTS
    MCCLAVE, SA
    PFEIFER, MA
    PETERSON, HR
    SCHUMER, MP
    GASTROENTEROLOGY, 1993, 104 (04) : A635 - A635
  • [42] ELEVATED PLASMA PRORENIN MAY BE A MARKER OF NEPHROPATHY IN TYPE-II DIABETIC-PATIENTS
    ANDERSON, RW
    SHAW, S
    HSUEH, WA
    CLINICAL RESEARCH, 1991, 39 (02): : A455 - A455
  • [43] CLINICAL EFFICACY AND TOLERANCE OF ACARBOSE IN THE TREATMENT OF NON-INSULIN-DEPENDENT DIABETIC-PATIENTS (TYPE-II)
    DELEIVA, A
    PINON, F
    TEBAR, J
    ESCOBARJIMENEZ, F
    DELACALLE, H
    HERRERAPOMBO, JL
    SOLER, J
    PALLARDO, LF
    GIL, E
    GUARDIOLA, E
    ARROYO, A
    INIGO, P
    CAMPOS, MM
    FERNANDEZSOTO, M
    GONZALEZ, A
    MUNOZTORRES, M
    LIGORRIA, C
    MEDICINA CLINICA, 1993, 100 (10): : 368 - 371
  • [44] THE 24-HOUR EFFECTS OF GLYBURIDE AND CHLORPROPAMIDE AFTER CHRONIC TREATMENT OF TYPE-II DIABETIC-PATIENTS
    PROSSER, PR
    KOSOLA, JW
    BOWERS, CY
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1985, 289 (05): : 179 - 185
  • [45] LIPOPROTEIN(A) LEVELS IN TYPE-II DIABETIC-PATIENTS ARE NOT INFLUENCED BY METABOLIC CONTROL OR BY MICROALBUMINURIA
    ZAMBON, S
    BALDOENZI, G
    BAIOCCHI, M
    NOSADINI, R
    MANZATO, E
    CREPALDI, G
    DIABETES CARE, 1994, 17 (12) : 1548 - 1549
  • [46] EARLY-ONSET OF PHARMACODYNAMIC EFFECTS OF GLIMEPIRIDE IN TYPE-II DIABETIC-PATIENTS
    WERNICKEPANTEN, K
    HAUPT, E
    PFEIFFER, C
    MAYER, A
    DRAEGER, KE
    DIABETOLOGIA, 1994, 37 : A163 - A163
  • [47] SOCIAL-ENVIRONMENT AND REGIMEN ADHERENCE AMONG TYPE-II DIABETIC-PATIENTS
    GLASGOW, RE
    TOOBERT, DJ
    DIABETES CARE, 1988, 11 (05) : 377 - 386
  • [48] EFFECT OF SOCIAL-FACTORS ON METABOLIC IMPROVEMENT IN TYPE-II DIABETIC-PATIENTS
    YAMAMOTO, W
    ORIGASA, H
    YAGINUMA, T
    KANAZAWA, Y
    INTERNAL MEDICINE, 1993, 32 (10) : 763 - 767
  • [49] ANTICOAGULANT PROTEIN-C IN TYPE-II DIABETIC-PATIENTS WITH AND WITHOUT MICROALBUMINURIA
    VEGLIO, M
    MORMILE, A
    GIROTTO, M
    ROSSETTO, P
    AUTINO, R
    GRUDEN, G
    CAVALLOPERIN, P
    DIABETOLOGIA, 1994, 37 : A194 - A194
  • [50] CLINICAL CHARACTERIZATION OF RESPONDERS TO ORAL SULFONYLUREA AGENTS IN TYPE-II DIABETIC-PATIENTS
    OSEI, K
    CLINICAL RESEARCH, 1986, 34 (02): : A431 - A431